S. Prey
- Dermatology top 0.5%
- Immunology top 5%
- Psoriasis: Treatment and Pathogenesis 6
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers 21
- Cutaneous Melanoma Detection and Management 6
- CAR-T cell therapy research 6
- Rheumatology top 5%
-
- Vascular Malformations and Hemangiomas 12
-
- Melanoma and MAPK Pathways 9
-
- melanin and skin pigmentation 6
-
- Nonmelanoma Skin Cancer Studies 6
- Co-authors
- C. PaulC. Léauté‐LabrèzeKhaled EzzedineP. JolyF. AubinS. AractingiPierre‐Antoine GourraudB. Cribier
- Cited by
- DermatologyImmunologyOncology
- Journals
- Journal of the European Academy of Dermatology and Venereology (10 papers)British Journal of Dermatology (6 papers)Journal of Immunotherapy (3 papers)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
S. Prey
60 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 96
- Dermatology 584
- Immunology 769
- Oncology 607
- Pathology and Forensic Medicine 298
- Rheumatology 249
Countries citing papers authored by S. Prey
This map shows the geographic impact of S. Prey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Prey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Prey more than expected).
Fields of papers citing papers by S. Prey
This network shows the impact of papers produced by S. Prey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Prey. The network helps show where S. Prey may publish in the future.
Co-authorship network
The 25 scholars most cited alongside S. Prey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 3 | |
| 5 | 2021 | 15 | |
| 6 | 2021 | 15 | |
| 7 | 2021 | 5 | |
| 8 | 2020 | 1 | |
| 9 | 2020 | 4 | |
| 10 | 2019 | 1 | |
| 11 | 2017 | 208 | |
| 12 | 2017 | 28 | |
| 13 | 2017 | 30 | |
| 14 | 2017 | 112 | |
| 15 | 2010 | 217 | |
| 16 | 2010 | 114 | |
| 17 | 2010 | 104 | |
| 18 | 2009 | 113 | |
| 19 | 2008 | 9 | |
| 20 | 2008 | 5 |
About S. Prey
S. Prey is a scholar working on Dermatology, Oncology and Immunology, having authored 64 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (21 papers), Vascular Malformations and Hemangiomas (12 papers), Melanoma and MAPK Pathways (9 papers), Psoriasis: Treatment and Pathogenesis (6 papers), Cutaneous Melanoma Detection and Management (6 papers), CAR-T cell therapy research (6 papers), melanin and skin pigmentation (6 papers) and Nonmelanoma Skin Cancer Studies (6 papers). The work is most often cited by research in Dermatology (584 citations), Immunology (769 citations) and Oncology (607 citations). S. Prey has collaborated with scholars based in France, United States and Italy. Frequent co-authors include C. Paul, C. Léauté‐Labrèze, Khaled Ezzedine, P. Joly, F. Aubin, S. Aractingi, Pierre‐Antoine Gourraud, B. Cribier, Martine Bagot and M‐A Richard‐Lallemand. Their work appears in journals such as Journal of the European Academy of Dermatology and Venereology, British Journal of Dermatology, Journal of Immunotherapy, Journal of Clinical Oncology and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.